Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose naloxone to shorten extubation time after general anesthesia
ChiCTR2400080013Phase 4Not yet recruiting
- Sponsor
- Taizhou Hospital of Zhejiang Province
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of naloxone in None (2 arms), sponsored by Taizhou Hospital of Zhejiang Province. Primary endpoint: Anesthesia recovery time. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
naloxone
Beyond the preview
Go deeper on ChiCTR2400080013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080013.